Hospitals represent 65% of the end user category and lobectomy accounts for 42% of application demand in 2026. The lung cancer surgery market was valued at USD 1.51 billion in 2025 and is projected to reach USD 2.8 billion by 2036, creating an incremental opportunity of USD 1.2 billion between 2026 and 2036.